Paper · 17536308

HER-2/neu expression in glioblastoma multiforme.

Haynik DM and 2 others. Appl Immunohistochem Mol Morphol, 2007. Cited by 25 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. HER-2/neu expression in glioblastoma multiforme. Papers, record 17536308. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17536308

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: HER-2/neu expression in glioblastoma multiforme.; PubMed
Journal: Appl Immunohistochem Mol Morphol; PubMed
Year: 2007; PubMed
Publication types: Journal Article; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/17536308/; PubMed
DOI: https://doi.org/10.1097/01.pai.0000213133.09160.da; PubMed
The journal: https://conductscience.org/library/journal-index/100888796; PubMed
Citations, by iCite: 25; iCite
Relative citation ratio, by iCite: 0.49; iCite
Revised in PubMed: 2026-01-28; PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Haynik DM	Denise M
2	Roma AA	Andres A
3	Prayson RA	Richard A

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Glioblastoma	Major topic
Erb-b2 Receptor Tyrosine Kinases	Major topic
Adult
Aged
DNA, Neoplasm
Female
Follow-Up Studies
Humans
Immunohistochemistry
In Situ Hybridization, Fluorescence
Male
Middle Aged
Neoplasm Proteins
Retrospective Studies

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.

PMID	Title	Journal	Year	In Papers	Source
40,227,788	The Co-Expression and Cellular Location of HER Family Members, EGFRvIII, Putative Cancer Stem Cell Biomarkers CD44 and CD109 in Patients with Glioblastoma, and Their Impacts on Prognosis.	Cancers (Basel)	2025	https://conductscience.org/library/papers/40227788	PubMed
37,404,752	CAR-NK cell therapy for glioblastoma: what to do next?	Front Oncol	2023	https://conductscience.org/library/papers/37404752	PubMed
34,572,775	Current Immunotherapeutic Strategies for the Treatment of Glioblastoma.	Cancers (Basel)	2021	https://conductscience.org/library/papers/34572775	PubMed
34,298,615	Advances in Immunotherapy for Adult Glioblastoma.	Cancers (Basel)	2021	https://conductscience.org/library/papers/34298615	PubMed
33,854,909	An immunohistochemical study of HER2 expression in primary brain tumors.	Biomedicine (Taipei)	2020	https://conductscience.org/library/papers/33854909	PubMed
33,053,763	Present and Future of Anti-Glioblastoma Therapies: A Deep Look into Molecular Dependencies/Features.	Molecules	2020	https://conductscience.org/library/papers/33053763	PubMed
31,266,784	An Anticancer Drug Cocktail of Three Kinase Inhibitors Improved Response to a Dendritic Cell-Based Cancer Vaccine.	Cancer Immunol Res	2019	https://conductscience.org/library/papers/31266784	PubMed
29,651,429	Therapeutic Potential of Thymoquinone in Glioblastoma Treatment: Targeting Major Gliomagenesis Signaling Pathways.	Biomed Res Int	2018	https://conductscience.org/library/papers/29651429	PubMed
25,893,308	IGFBP2 potentiates nuclear EGFR-STAT3 signaling.	Oncogene	2016	https://conductscience.org/library/papers/25893308	PubMed
24,747,440	Profilin-1 phosphorylation directs angiocrine expression and glioblastoma progression through HIF-1α accumulation.	Nat Cell Biol	2014	https://conductscience.org/library/papers/24747440	PubMed

1 to 10 of 13

See all 13 cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Gene	NCBI Gene ID	Linked by	In Genes	Source
ERBB2	2,064	PubTator's text mining	https://conductscience.org/library/genes/2064	NCBI Gene
TXK	7,294	PubTator's text mining	https://conductscience.org/library/genes/7294	NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17536308

GET https://conductscience.org/api/papers/v1/17536308/authors

API reference For AI assistants